AstraZeneca Acquires Modella AI to Expand Oncology AI Capabilities
AstraZeneca has acquired Modella AI, as announced by the Boston-based artificial intelligence company on Tuesday. Focused on life sciences, the
Read moreAstraZeneca has acquired Modella AI, as announced by the Boston-based artificial intelligence company on Tuesday. Focused on life sciences, the
Read moreEli Lilly and Company (NYSE: LLY) announced a groundbreaking collaboration with NVIDIA to build the most powerful supercomputer ever owned
Read moreBeonchip has introduced the next generation of Microfluidic chips! Simplified Organ-on-Chip Technology for In Vitro Research and Drug Discovery Discover
Read moreEnhancing the Accuracy of Plasma Protein Binding (PPB) Assays for Challenging Drug Candidates An Inotiv Case Study Evaluating Sovicell’s TRANSIL
Read moreDetermination of the Plasma Protein Binding of Liraglutide Using the EScalate* Equilibrium Shift Assay A Sovicell White Paper Evaluation of
Read moreIn the vast landscape of pharmaceutical research and development, one significant challenge that researchers face is the availability of suitable
Read moreCantargia AB has announced a landmark agreement with Japanese pharma giant Otsuka Pharmaceutical Co., Ltd., granting Otsuka exclusive global rights
Read moreSeNostic is Revolutionising Neurodegenerative Disease Detection and Drug Discovery with Cutting-Edge Technology A SeNostic Company Presentation SeNostic aims to enhance
Read moreSanofi has announced a definitive agreement to acquire clinical-stage biotech firm Vigil Neuroscience, Inc., in a move to expand its
Read moreAdvanced single-cell technologies, particularly methods such as single-cell RNA sequencing (scRNA-seq), coupled with sophisticated computational tools and the increasing accessibility
Read more